Methods for the administration of CRF antagonist

TW202637130APending Publication Date: 2026-09-16NEUROCRINE BIOSCIENCES INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114148431
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-12-11
Filing Date
2025-12-10
Publication Date
2026-09-16
Patent Text Reader

Abstract

(CRF1) receptor antagonist to a patient in need thereof, wherein the patient is being concomitantly administered a strong cytochrome
Need to check novelty before this filing date? Find Prior Art